Cencora, Inc.
USUSDCencora, Inc. (LSE:0HF3) — Other Pharmaceuticals. Брой борси, на които се търгуват акциите на компанията: 2. На тази страница — цена и график, дивиденти, най-големи акционери и история на броя на акциите.
За Компанията
- Уебсайт
- cencora.com
- Сектор
- Health Care · Other Pharmaceuticals
- Централа
- Chesterbrook, United States
- Изпълнителен Директор
- Steven H. Collis
- Служители
- 44 000
- Основана
- 2001
- Акции в Обращение
- 190.83 млн към 2026-07-31
- Свободно Търгуеми Акции
- 180.25 млн
- Пазарна Капитализация
- 58.98 млрд USD
- Инсайдери
- 4.3%
- Институционални Инвеститори
- 99.63%
- Отрасъл (SIC)
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- ISIN
- US03073E1055
- LEI
- AI8GXW8LG5WK7E9UD086
- Коефициент на Изплащане
- 17.8%
- FCF
- 4.06 млрд USD
- Payout / FCF
- 12%
- Дълг
- 11.7 млрд USD2.2 г. FCF
- Дивидентна История
- 25 г.
- Печалба, FCF и изплатени дивиденти — за 12-те месеца до 30.06.2026 (последният отчет на компанията).
Описание
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Дивиденти
Cencora, Inc. (COR) изплаща дивиденти на тримесечие. Годишно (12 месеца до и включително най-скорошното обявено плащане): 2.4 USD на акция (плащания: 4). Това е около 0.74% от текущата цена на акцията. Според историята на плащанията следващата екс-дивидентна дата се очаква около 13.11.2026. Години непрекъснати дивиденти: 25.
| Екс-Дата | Изплащане | Сума | % | Вид | Тикер |
|---|---|---|---|---|---|
| 2026-08-14 | 2026-08-31 | 0.6000 USD | 0.2/0.8 % | тримесечно | US:COR |
| 2026-05-15 | 2026-06-01 | 0.6000 USD | 0.2/0.9 % | тримесечно | US:COR |
| 2026-02-13 | 2026-03-02 | 0.6000 USD | 0.2/0.7 % | тримесечно | US:COR |
| 2025-11-14 | 2025-12-01 | 0.6000 USD | 0.2/0.6 % | тримесечно | US:COR |
| 2025-08-15 | 2025-09-03 | 0.5500 USD | 0.2/0.7 % | тримесечно | US:COR |
| 2025-05-16 | 2025-06-02 | 0.5500 USD | 0.2/0.8 % | тримесечно | US:COR |
| 2025-02-14 | 2025-03-03 | 0.5500 USD | 0.2/0.9 % | тримесечно | US:COR |
| 2024-11-15 | 2024-11-29 | 0.5500 USD | 0.2/0.9 % | тримесечно | US:COR |
| 2024-08-09 | 2024-08-26 | 0.5100 USD | 0.2/≈0.6 % | тримесечно | US:COR |
| 2024-05-09 | 2024-05-24 | 0.5100 USD | 0.2/≈0.6 % | тримесечно | US:COR |
| 2024-02-08 | 2024-02-26 | 0.5100 USD | 0.2/≈0.6 % | тримесечно | US:COR |
Най-Големи Притежатели
| Притежател | Дял | Акции | Дата на Доклада |
|---|---|---|---|
| BlackRock | 9.54% | 18.21 млн | 2026-06-30 |
| Vanguard Capital Managem… | 6.49% | 12.38 млн | 2026-06-30 |
| Vanguard Portfolio Manag… | 5.04% | 9.61 млн | 2026-06-30 |
| State Street Corporation | 4.86% | 9.27 млн | 2026-06-30 |
| T. Rowe Price Investment… | 3.88% | 7.41 млн | 2026-06-30 |
| Price (T.Rowe) Associate… | 3.74% | 7.13 млн | 2026-06-30 |
| JPMORGAN CHASE & CO | 3.11% | 5.94 млн | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.07% | 5.87 млн | 2026-06-30 |
| Geode Capital Management… | 2.86% | 5.45 млн | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.64% | 5.04 млн | 2026-06-30 |
| Boston Partners | 2.55% | 4.87 млн | 2026-06-30 |
| Wellington Management Gr… | 2.39% | 4.56 млн | 2026-06-30 |
| T. ROWE PRICE CAPITAL AP… | 2.33% | 4.44 млн | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.1% | 4.01 млн | 2026-06-30 |
| VANGUARD SPECIALIZED FUN… | 1.59% | 3.03 млн | 2026-07-31 |
| iShares Trust-iShares Co… | 1.36% | 2.59 млн | 2026-08-31 |
| Fidelity Concord Street… | 1.32% | 2.52 млн | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.25% | 2.38 млн | 2026-08-31 |
| VANGUARD INDEX FUNDS-Van… | 0.92% | 1.76 млн | 2026-06-30 |
| -Price (T.Rowe) U.S. Val… | 0.85% | 1.62 млн | 2026-06-30 |
| COLLIS STEVEN HOWARD (Of… | ≈0.16% | 305 913 | 2025-09-16 |
| CLEARY JAMES F. JR. (Chi… | ≈0.08% | 160 357 | 2026-03-11 |
| MAUCH ROBERT P. (Chief E… | ≈0.03% | 65 393 | 2026-02-20 |
| DURCAN DERMOT MARK (Dire… | ≈0.02% | 31 767 | 2026-06-18 |
| BATTAGLIA SILVANA (Offic… | ≈0.01% | 23 624 | 2026-06-30 |
| CAMPBELL ELIZABETH S (Of… | ≈0.01% | 19 455 | 2026-08-24 |
| GREENBERG LON R (Directo… | ≈0.01% | 17 128 | 2026-09-16 |
| KRIKORIAN LAZARUS (Offic… | ≈0.01% | 16 169 | 2026-09-01 |
| NALLY DENNIS M (Director… | ≈0.01% | 13 188 | 2026-07-31 |
| The Vanguard Group | — | — | — |
| Walgreens Boots Alliance… | — | — | 2025-02-06 |
